In the News: September 21–27
By Sg2 TeamThis week: Trends in emergency room visits, an innovative donor strategy, and reducing unnecessary c-sections.
- Share
This week: Trends in emergency room visits, an innovative donor strategy, and reducing unnecessary c-sections.
This week: Health care market concentration trends, the expanding NP role, and uninsured rate increases for some groups.
This week: CAR T-cell therapy approval, Anthem restricts HOPD imaging reimbursement, and sepsis leads costs for Medicare discharges
This week: estimate of Americans in nursing homes, clinicians’ familiarity with MACRA, and brain abnormalities after concussions.
This week: Incentives increase primary care visits, following the 340B drug payment debate, and health systems leveraging crowdfunding.
This week: Human embryo modified via CRISPR, VA expanding virtual health access, and state variation in care experiences
This week: new digital pre-certification program, growth in US health services deal value, and US mental illness estimates
This Week: First FDA approved gene therapy, rural EMS response times and a “DNA app store”
This week: ACA repeal falters in Senate, CMS proposes outpatient TKA, and HOPD site neutral payment updates
This week : Narrow networks may exclude high quality care, trends in end-of-life care, and growth across alternative payment models.
This week: Impact of ACA, a tool that helps oncology patients, and NY health systems join HIEs
This week : chronic pain management, CBO scores Senate ACA repeal bill, growth of high deductible health plans
This week: ED cost of care, ED visits by seniors, and cancer treatment planning using AI
This week: NICU safety, housing assistance and the uninsured, and exercise therapy for PAD
This week: Pfizer donates naloxone, unnecessary medical testing, and CBO scores the AHCA
This week: AMI and CABG bundled payments, antibiotic-resistant pathogens, and HCV+ kidney transplants
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."